Stay updated on Optimal Tenecteplase Dose in Stroke Clinical Trial
Sign up to get notified when there's something new on the Optimal Tenecteplase Dose in Stroke Clinical Trial page.

Latest updates to the Optimal Tenecteplase Dose in Stroke Clinical Trial page
- Check6 days agoChange Detected- Revision label updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.4.2 is now shown. The previous Revision: v3.4.1 note and a general government funding-status notice were removed.SummaryDifference0.3%

- Check41 days agoChange DetectedA general funding-status notice was added. The page revision updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check48 days agoChange DetectedNew UI/text changes include adding a Show glossary option and updating the footer to display 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'. The prior footer entries 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed.SummaryDifference0.2%

- Check62 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4 with no visible changes to study details or layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check83 days agoChange DetectedThe page now includes a consolidated Locations section with New South Wales, Queensland, South Australia, Victoria, and Auckland, replacing previous separate location headings; this changes how sites are listed on the page.SummaryDifference0.5%

Stay in the know with updates to Optimal Tenecteplase Dose in Stroke Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Optimal Tenecteplase Dose in Stroke Clinical Trial page.